Here’s why WELL Health is down and why you should buy it: Ventum

Delayed financials from WELL Health (WELL Health Stock Quote, Chart, News, Analysts, Financials TSX:WELL) mean an opportunity for investors.

On March 28, WELL announced that its audited financial statements would be delayed by a request from Civil Division of the United States Attorney’s Office for the Northern District of California which is investigating certain billing practices.

“The company does not expect the resolution of the matter to have a material effect on the company’s cash position or available resources. The company and Circle Medical are currently working diligently to finalize the company’s annual consolidated financial statements at the earliest possible date. The company currently expects to be in a position to file the required filings on or before April 15, 2025,” WELL said.

Goff summarized the event, offering that the potential effect is minimal.

“WELL announced that the filing of its Q4/24 and 2024 results have been delayed as the Company addresses a review by the Civil Division of the US Attorney’s Office for the Northern District of California (USAO),” the analyst wrote. “USAO is investigating certain of Circle Medical’s US billing practices. WELL has been responding to a voluntary request for information since September 2024. Where Circle’s proportionate EBITDA contribution represents